EMEA-001696-PIP01-14-M01

Key facts

Active substance
Omecamtiv mecarbil
Therapeutic area
Cardiovascular diseases
Decision number
P/0172/2019
PIP number
EMEA-001696-PIP01-14-M01
Pharmaceutical form(s)
Modified-release tablet
Condition(s) / indication(s)
Treatment of heart failure
Route(s) of administration
Oral use
Contact for public enquiries
Amgen Europe B.V.

E-mail: medinfointernational@amgen.com
Tel. +44 (0)1223 420305
Fax +44 (0)1223 423049

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating